Skip to main content

Table 2 Primary and secondary outcomes

From: Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial

 

HS1d

HS3d

Difference (90% CI)

p-value

Primary outcome

n = 53

n = 50

  

 Wang CSS at 72 h of treatment (mean ± SD)

3,4 ± 2,0

2.7 ± 1.7

0.7 (0.1–1.3)

0.064

Secondary outcomes

n = 59

n = 57

  

 Wang CSS at 48 h of treatment (mean ± SD)

4.9 ± 2.1

4.1 ± 2.4

 

0.055

 Clinical remission in days (mean ± SD)

2.9 ± 1.4

2.2 ± 1.6

 

0.043

 Enteral nutrition (n, %)

29 (49.1)

21 (36.8)

 

0.181

 Oxygen supplementation (n, %)

30 (50.8)

21 (36.8)

 

0.129